Introduction: HLA-G is a major histocompatibility complex (MHC), class Ib molecule that is selectively expressed at the fetal-maternal interface. It is thought to play a role in protecting the fetus from the maternal immune response. Interestingly, the preimplantation embryo development (Ped) gene product Qa-2 is also a mouse MHC class Ib protein that affects cleavage and division of preimplantation mouse embryos and subsequent embryonic survival. Data from many human in vitro fertilization (IVF) clinics suggest that the mouse Ped phenomenon also exists in human because embryos fertilized at the same time have different cleavage rates and consequently different IVF outcomes. As HLA-G is expressed in human early embryos, it is highly regarded as the functional homologue of Qa-2. Whether HLA-G expression is correlated with the cleavage rate of human embryos has great potential clinical value. Methods: In this study, 45 human early abnormal fertilized embryos (3 PN) from patients undergoing in vitro fertilization were used to test the effects of HLA-G knock-down via infection with adenovirus carrying its specific siRNA on the cleavage rate in a 2-day culture period. One-way ANOVA, Post hoc and Chi-square were used to compare groups. A p-value smaller than 0.05 was considered statistically significant. Results: Knocking-down HLA-G in human pre-implantation stage embryos resulted in a higher cell arrest rate and a slower cleavage rate.
Introduction uman leukocyte antigen (HLA)-G is a nonclassical major histocompatibility complex class I or Class Ib molecule that is primarily expressed at the fetal-maternal interface. It is thought to play a role in protecting the fetus from the maternal immune response. HLA-G is also expressed in preimplantation human embryos (1 -4) . Embryos capable of secreting soluble HLA-G are associated with a higher implantation rate, ongoing gestation and live birth rates in in vitro fertilization (IVF) cycles (5 -7) . In human, HLA-G protein is expressed in 75% of embryos at preblastocyst stage and in all at blastocyst stage. More importantly, HLA-G expressing embryos JRI 216 have an increased development rate (1) .
Human HLA-G sequence possesses the highest homologue to that of the mouse Q7 and preimplantation embryo development (Ped) gene encoding Qa-2 protein (8) . HLA-G and Qa-2 proteins also have similar functions (2, 8 -12) . HLA-G/Qa-2 proteins are restricted in the plasma membrane lipid rafts in the fast-cleaving human/ mouse embryos (9, 11) . It is also reported that the mouse Ped gene regulates the cleavage and division and subsequent survival of preimplantation mouse embryos (13) . Qa-2 is expressed in mouse preimplantation embryos from 2-cell through the blastocyst stage (14, 15) . Two phenotypes of the Ped gene, fast and slow, have been defined. Ped fast preimplantation embryos develop at a significantly faster rate, both in vivo and in vitro, compared with Ped slow embryos (13, 16, 17) . HLA-G is suggested to be the human functional homologue of the mouse Qa-2 protein (2, 8, 9) .
The Ped gene phenotype, fast and slow preimplantation embryo development, also exists in human. Data from many IVF clinics showed that embryos from pools of oocytes fertilized simultaneously were not necessarily synchronized in their development, suggesting that gene(s) similar to Ped exist in human which could influence human preimplantation embryo cleavage (18) . In addition, embryos that divide more rapidly are more likely to lead to a pregnancy. One report has suggested the fast rate of human embryonic development is associated with expression of HLA-G mRNA (2) . The cleavage rate of embryos at 48 h after fertilization is significantly correlated with sHLA antigens in the culture medium (19) . HLA-G can act as a signaling molecule to induce proliferation of resting T cells (11) . We hypothesized that HLA-G could affect early human embryonic development. In this study, we designed recombinant adenoviral vectors encoding siRNA against HLA-G for down-regulating HLA-G expression. We infected human early embryos with these siRNA viral vectors to test the effects of HLA-G on embryo cleavage rate.
Methods

Construction of HLA-G siRNA vectors:
The construction of the HLA-G siRNA vectors and adenoviral infection in vitro was described elsewhere (20) . Hairpin siRNA template that targets the HLA-G gene was inserted into the shuttle vector 1.0-CMV at the XhoI and SpeI restriction enzyme sites (Ambion, Austin, TX, USA). The 21 nt HLA-G target sequence (GenBank accession no. NM002127,3217-3228,3674-3680) was served as a basis for the design of the two complementary 55-mer oligonucleotides. The 55 bp oligonucleotide of hairpin siRNA template was designed by Ambion's Web-Based siRNA Design Resources to interfere exclusively with HLA-G. For a negative control, the oligo sequence was scrambled and arranged not to affect any known human genes ( Table 1 ). After confirmation of the knockdown effect of HLA-G on JEG-3 cell line, the siRNA was cloned into the adenoviral vector (Ad5). The viruses were harvested, amplified and titered using a kit according to the manufacturer's instructions (Ambion, Austin, TX, USA). A multiplicity of infection (MOI) of 100 was applied for both the mouse and human embryos.
Adenoviral infection of mouse embryos: Mouse embryos at the pronuclear stage were flushed out from the oviducts of the super-ovulated Kunming mice in M2 culture medium (Sigma-Aldrich, M7167, UK). Adenoviral vectors with scrambled HLA-G siRNA sequence were added in concentrations of 10 4 pfu/ml, 10 5 pfu/ml, 10 6 pfu/ml and 10 7 pfu/ml, respectively to the zona-free embryos in M2 medium. Then it was supplemented by Bovine Serum albumin (BSA) to a final concentration of 4 mg/ml. Polybrene (4 μg/ml) was also added to improve infection efficiency. After 2 h of culture, embryos were rinsed with M2 medium and transferred to a CO 2 balanced fresh M16 medium covered with mineral oil. The growth of the embryos was observed in the following two days. In the same way, 4-cell embryos were exposed to the adenoviral vectors for 2 h and then cultured for 24 h. Embryos were fixed with 4% parafor- maldehyde (PFA) in phosphate buffer solution (PBS) and then were put in the X-Gal solution (20 mg/ml Bromo-chloro-indolyl-galactopyranoside dissolved in dimethylformamide) overnight at 37ºC to stain the galactose-expressing embryos.
Experimental design and adenoviral infection of
human embryos: Collection of human embryos and their research use herein were approved by the Ethics Committee of Tangdu Hospital of the FMMU. Embryos were obtained with informed consent from patients who had undergone IVF in the Fertility Center of Tangdu Hospital from March to July 2007. The embryos with abnormal fertilization (3 PN) that were not appropriate for transfer to uterus were selected for this study. The protocols of ovarian induction and in vitro fertilization have been previously described in detail (1) . The day of egg retrieval was termed as day 0; insemination was performed on day 0 and the next days were termed as day 1-day 3. The 4-to 8-cell staged embryos collected on day 3 were deprived from their zona-pellucida and were grouped randomly into 3 groups: the mock control (group 1), the scrambled control (group 2) and the HLAG-siRNA group (group 3). The zona-free embryos were cultured in culture medium with or without adenoviral vectors for 1 hour before being put back in normal culture media. In group 1, the embryos were treated with 4 μg/ml polybrene without any adenoviral vectors. In group 2, the embryos transfected with adenoviral vector containing the scrambled siRNA. In group 3, the embryos transfected with the adenoviral vector containing HLAG-siRNA. After 2 days of culture (day 5), embryos were fixed and the number of arrested embryos and blastomeres per embryo were counted.
The adenoviral vectors were diluted to a concentration of 10 6 pfu/ml in the medium supplemented with 4 μg/ml polybrene. After incubation for an hour, the zona-free embryos were rinsed and cultured individually in 10 μl of fresh culture medium under mineral oil. On day 5, the embryos were fixed in 4% PFA for 30 min, permeabilized with 0.2% Triton X-100 for 10 min and stained with 5 μg/ml fluorochrome 4,6-diamidino-2-phenylindole (DAPI, Roche 236276, UK) in PBS for 20 min. The number of blastomeres was counted under a fluorescence microscope.
The adenoviral vector with HLA-G siRNA target sequence exerted a powerful and specific knockdown effect on HLA-G expressing cells (JEG-3 cells) .
The expression of LacZ reporter gene in the blastomeres which were stained blue by X-Gal was regarded as the evidence of being infected by the adenoviral vectors.
Statistical analysis: One-way ANOVA, Post hoc and chi-square were used to compare the number of blastomeres per embryo in groups and the percentage of arrested embryos. The means were shown as Mean ± SD. A p-value of <0.05 was considered statistically significant.
Results
Effects of HLA-G adenoviral infection on the cleavage of human embryos:
A total of 45 human embryos were obtained. They were abnormally fertilized embryos with three pronuclei (3 PN) at 4-8 cell stage including 14 grade 1 and 31 grade 2 embryos. The donors' mean age was 29.64 ± 0.48 (ranging from 24 to 44, Table 2 ). There was no statistical differences regarding the average cell count, grade or the donors' age among groups 1, 2 and 3 ( Table 2 ). After 2 days of culture following transfection, 53.33% and 92.31% embryos, respectively from group 2 and 3 arrested which were significantly higher than that of group 1 (17.65%) ( Table 3 ). The number of blastomeres after 4 days of transfection was 17.71 ± 6.57, 10.87 ± 4.16 and 7.69 ± 1.55, respectively in groups 1, 2 and 3 (Table 3 ). There was significant differences between any two groups among the three, with a p-value of 0.004 (between group 1 
Efficiency of adenoviral vector transfection on
HLA-G expressing cells and mouse embryos:
The HLA-G mRNA's relative expression decreased significantly (about 24% less) in HLAG-siRNA group compared with the scrambled control 48 h after infection. The HLA-G protein's relative expression decreased significantly (about 50% less) in the Ad5-siRNA group versus the Ad5-scrambled control. Mouse 4-8 cell embryos can be infected with ≥10
6 pfu/ml Ad5 vectors with about 50% efficiency (Figure 1 ). No obvious toxicity was found during embryo culture. However, at 10 7 pfu/ml, the adenoviral vectors showed toxicity to the embryos despite a higher infection rate (Data not shown). We then chose to use 10 6 pfu/ml for the human embryo studies.
Discussion RNA interference, known as RNAi, is an efficient gene knock-out technology. One of the biggest challenges in the use of RNAi to study gene function in mammalian cells is the efficiency of successful delivery of small interfering RNAs (siRNAs) or siRNA expression vectors into the cells. The Ad serotype 5 (Ad5) vector used in this study was a replication defective vector encoding bacterial β-galactosidase (lacZ) gene as a marker. The Ad vector has high infection efficiency with a remarkable gene knockdown effect in the JEG-3 cells cultured in vitro. The NK-mediated cytotoxicity of HLA-G knocking-down cells is increased (20) . Furthermore, they are easy and safe to manipulate. The purified virus has less toxicity to the cells as compared with lipophilic transfection reagents. Despite the application of the Ad vectors in basic research and gene therapy, little information is available on Ad vector-mediated gene transfer into human embryos. We observed that transfection of the virus in a concentration of 10 7 pfu/ml has potential toxicity to 2-cell human embryos by delaying their developmental speed and destroying their morphology (data not shown). Non-infectious viral particles can provoke a cell-mediated immune response, exert direct toxic effects on cells and consequently disturb surface interactions between blastomeres which all are harmful for pre-implantation-stage embryos. In order to reduce the toxicity to embryos, 10 6 pfu/ml titer was applied in this study.
To our knowledge, this is the first report using siRNA-expressing Ad vector to transfect human early embryo in HLA-G function study. The adenoviral vector targeting HLA-G provides a possibility to investigate and compare embryos with HLA-G expression with their deficient analogue. As embryo cleavage speed is an indicator of successful IVF outcome (5-7), our findings may also shed light on the clinical work. From our data in mock control group, the embryos which had not been exposed to Ad vector showed an unusual low cleavage and high arrest rate during the 2 days of culture (Table 3 ). The average number of blastomeres per embryo was only 17.71 ± 6.57 and most of the morulas could not form blastocysts (Table 3 ). It might have been caused by the abnormally fertilized three pronuclei (3 PN) human embryos we used whose cleaving rate were always slowed-down (17) . In the study by Jurisicova et al. (4), the blastocyst formation rate from 3 PN human embryos was significantly lower than that from 2 PN (normal) embryos (20% versus 56%). Aneuploidy embryos are more likely to be blocked on day 3 than the euploidy ones. In our study, the HLA-G down-regulated embryos had a significant slower cleavage rate, consistent with the previous findings (2, 20) . In contrast, embryos expressing HLA-G were associated with a higher cleaving rate and better morphology (5 -7).
In this study, we used 3-PN embryos instead of normally fertilized embryos. It is estimated that only about 50% of the IVF embryos are euploid, and self-correction occurs during the development toward the blastocyst stage (21) . With slight discontent, we believed that the effects of HLA-G on 3PN human embryos could represent its effects on normal embryos which were difficult ethically to be used in research. Importantly, we used the 3PN human embryos as the controls to reduce the influences of chromosomes on development.
Mice embryos expressing Qa-2 are characterized by the Ped fast phenotypes, which exhibit faster pre-implantation cleavage rate (both in vitro and in vivo), better survival to term, and higher birth and weaning weights compared with the embryos not expressing Qa-2 and showing Ped slow phenotypes (13, 22) . Chemical removal of the Qa-2 protein from the embryonic cell surface results in a slowing down of embryo development (23) . Additionally, antisense oligonucleotides to Qa-2 mRNA decrease the cleavage rate of the Ped fast embryos (24) . Conversely, transferring Qa-2 gene to the Qa-2-negative zygotes leads to the expression of Qa-2 and an increased cleavage rate (19, 25) . Addition of exogenous Qa-2 protein into the membrane of Ped-negative embryos also increases the rate of cleavage (26) .
Similar to Qa-2, HLA-G is also present in the lipid rafts in the cell membrane and can act as a signaling molecule to induce proliferation of resting T cells (11) . To date, seven HLA-G mRNA transcripts have been identified, which encode four membrane-bound isoforms (G1, G2, G3 and G4) and three soluble isoforms (G5, G6 and G7). Yao et al. (1) found that HLA-G3 and -G4 were the predominant isoforms expressed in human embryos. Transcription of HLA-G mRNA was triggered at 6-8 cell stage and increased as the embryos developed (1). All human blastocysts and 75% of pre-blastocyst expressed HLA-G protein.
Conclusion
We presumed that the expression of HLA-G protein increased human early embryo cleavage and its expression might facilitate blastomere cleavage rate and blastocyst formation in 4-to 8-cell-stage embryos. The adenoviral vector we constructed in this study was highly effective on transfection and thus provided a potent tool for further investigation in HLA-G function.
